55 Greens Farms Road
1st Floor
Westport, CT 06880
United States
203 409 5444
https://www.biosig.com
Sector(es): Healthcare
Industria: Medical Devices
Empleados a tiempo completo: 4
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Frederick D. Hrkac | President, Principal Executive Officer & Executive VP | N/D | N/D | 1967 |
Mr. Anthony Amato | CEO & Director | N/D | N/D | 1968 |
Dr. Budimir S. Drakulic Ph.D. | Chief Scientist | 169.64k | N/D | 1950 |
Mr. Andrew Gornell Ballou | Vice President of Investor Relations | N/D | N/D | N/D |
BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
La calificación ISS Governance QuickScore de BioSig Technologies, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.